Analysis of cerebrospinal fluid in racemose form of neurocysticercosis

被引：5

作者：

Bazan, Rodrigo ^{[1
]}

Odashima, Newton Satoru ^{[3
]}

Luvizutto, Gustavo Jose ^{[2
]}

Hamamoto Filho, Pedro Tadao ^{[1
]}

Zanini, Marco Antonio ^{[1
]}

Takayanagui, Osvaldo Massaiti ^{[3
]}

机构：

[1] Univ Estadual Paulista, Dept Neurol Psicol & Psiquiatria, Fac Med Botucatu, Botucatu, SP, Brazil

[2] Univ Estadual Paulista, Hosp Clin, Fac Med Botucatu, Botucatu, SP, Brazil

[3] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurociencias Ciencias Comportamento, BR-14049 Ribeirao Preto, SP, Brazil

来源：

ARQUIVOS DE NEURO-PSIQUIATRIA | 2015年 / 73卷 / 10期

关键词：

neurocysticercosis; racemose; cerebrospinal fluid; INTRATHECAL SYNTHESIS; SOLIUM CYSTICERCOSIS; TAENIA-CRASSICEPS; DISEASE; HYDROCEPHALUS; SERUM; IGG; SEX;

D O I：

10.1590/0004-282X20150120

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

The present work aimed to evaluate the pattern of CSF alterations in patients diagnosed with neurocysticercosis (NCC) in racemose form. Method: This is a retrospective cohort study of patients with diagnosis of NCC in racemose form. CSF samples from 26 patients were analyzed. After patient-chart analysis was performed descriptive analysis of case studies and comparison between sexes in relation to variables were obtained with CSF by Mann-Whitney and Student's t-tests. Results: The sexes did not differ statistically when compared to pleocytosis in CSF. Eosinophils were present in 31% in samples while the ELISA test presented 80% sensitivity in this case series. Of the patient total, 24 presented a meningitis pattern with Lymphocytic predominance. Conclusion: There was no difference in inflammatory pattern between the sexes, with predominance of lymphocytic meningitis and 80% sensitivity by ELISA test of CSF patients with racemose form of NCC.

引用

页码：852 / 855

页数：4

共 25 条

[1] Clinical and evolutive aspects of hydrocephalus in neurocysticercosis [J].

Agapejev, Svetlana ;

Pouza, Ana Flavia P. ;

Bazan, Rodrigo ;

Faleiros, Antonio Tadeu S. .

ARQUIVOS DE NEURO-PSIQUIATRIA, 2007, 65 (3A) :674-680

[2]

Agudelo Piedad, 2005, Biomed., V25, P518

[3]

[Anonymous], 1993, MMWR Recomm Rep, V42, P1

[4]

ARRIAGADA C, 1997, NEUROCISTICERCOSIS A

[5] Magnitude of the disease burden from neurocysticercosis in a developing country [J].

Bern, C ;

Garcia, HH ;

Evans, C ;

Gonzalez, AE ;

Verastegui, M ;

Tsang, VCW ;

Gilman, RH .

CLINICAL INFECTIOUS DISEASES, 1999, 29 (05) :1203-1209

[6] ANTICYSTICERCOUS ANTIBODIES IN SERUM AND CEREBROSPINAL-FLUID IN PATIENTS WITH CEREBRAL CYSTICERCOSIS [J].

CORONA, T ;

PASCOE, D ;

GONZALEZBARRANCO, D ;

ABAD, P ;

LANDA, L ;

ESTANOL, B .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1986, 49 (09) :1044-1049

[7] Neurocysticercosis: Focus on intraventricular disease [J].

Cuetter, AC ;

GarciaBobadilla, J ;

Guerra, LG ;

Martinez, FM ;

Kaim, B .

CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) :157-164

[8] SEX-RELATED SEVERITY OF INFLAMMATION IN PARENCHYMAL BRAIN CYSTICERCOSIS [J].

DELBRUTTO, OH ;

GARCIA, E ;

TALAMAS, O ;

SOTELO, J .

ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (03) :544-546

[9] Proposed diagnostic criteria for neurocysticercosis [J].

Del Brutto, OH ;

Rajshekhar, V ;

White, AC ;

Tsang, VCW ;

Nash, TE ;

Takayanagui, OM ;

Schantz, PM ;

Evans, CAW ;

Flisser, A ;

Correa, D ;

Botero, D ;

Allan, JC ;

Sarti, E ;

Gonzalez, AE ;

Gilman, RH ;

García, HH .

NEUROLOGY, 2001, 57 (02) :177-183

[10]

DELBRUTTO OH, 1988, REV INFECT DIS, V10, P1075

← 1 2 3 →